Biogena Group Invest AGWBO:BIO -5.41%64 Operating Margin % is 51.00% as of Jan. 2026, which is 106% above its 10-year median of 24.76. GuruFocus rates WBO:BIO with a GF Score™ of 64/100 and a GF Value™ of €3.45 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,951 Consumer Packaged Goods companies, Biogena Group Invest AG ranks better than 99.64% on this metric.
The historical rank and industry rank for Biogena Group Invest AG's Operating Margin % or its related term are showing as below:
WBO:BIO'
s Operating Margin % Range Over the Past 10 Years
Min: -22.66 Med: 24.76 Max: 53.26
Current: 51
WBO:BIO's Operating Margin % is ranked better than 99.64% of 1951
companies
in the Consumer Packaged Goods industry
Industry Median: 5.26
vs WBO:BIO: 51.00
Biogena Group Invest AG (WBO:BIO) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Biogena Group Invest AG Operating Margin % Related Terms
Biogena Group Invest AG Operating Margin % Historical Data
* Premium members only.
The historical data trend for Biogena Group Invest AG's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:BIO vs KHC, GIS, JBS: Operating Margin % Comparison
For the Packaged Foods subindustry, Biogena Group Invest AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biogena Group Invest AG Operating Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Biogena Group Invest AG's Operating Margin % falls into.
Biogena Group Invest AG Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Biogena Group Invest AG's Operating Margin % for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biogena Group Invest AG (WBO:BIO) has a Operating Margin % of 51.00% as of Jan. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Biogena Group Invest AG and its competitors. This is 106% above median its historical median of 24.76. According to the industry distribution chart, Biogena Group Invest AG ranks #7 out of 1951 companies in the Consumer Packaged Goods industry, placing it in the top 0.40000000000001%.
Is Biogena Group Invest AG's Operating Margin % too high?
Biogena Group Invest AG's current Operating Margin % of 51.00% is 106% above median its 10-year median of 24.76. The Consumer Packaged Goods industry median Operating Margin % is 5.26. Biogena Group Invest AG's value of 51.00% is 869.6% above this industry median. Based on the distribution chart, Biogena Group Invest AG ranks #7 out of 1951 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Biogena Group Invest AG has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Operating Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biogena Group Invest AG ranks #7 out of 1951 companies for Operating Margin %. This places Biogena Group Invest AG in the top 0% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 5.26. Biogena Group Invest AG's value of 51.00% is 869.6% above this benchmark. While the company's 10-year median is 24.76 vs. the industry median of 5.26, Biogena Group Invest AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Consumer Packaged Goods company?
The median Operating Margin % among Consumer Packaged Goods companies is 5.26, based on 1,951 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biogena Group Invest AG's current Operating Margin % of 51.00% is 869.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Biogena Group Invest AG and its competitors. For the Consumer Packaged Goods industry, the median Operating Margin % is 5.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biogena Group Invest AG's current Operating Margin % is 51.00%, which is 106% above median its own 10-year median of 24.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.45, compared to a current price of €4.20 — trading 21.7% above its estimated fair value. The current Operating Margin % is 51.00%, which is 106% above median its 10-year median of 24.76 and 869.6% above the Consumer Packaged Goods industry median of 5.26. Biogena Group Invest AG's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Operating Margin % is 51.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued.
The current stock price of €4.20 is trading 21.7% above its estimated GF Value™ of €3.45.
GuruFocus considers Biogena Group Invest AG to be Modestly Overvalued.
Key valuation signals for WBO:BIO:
Operating Margin %: 51.00% (106% above median its 10-year median of 24.76)
GF Value™: €3.45 vs. price of €4.20 (21.7% above fair value)
Industry Position: 869.6% above the Consumer Packaged Goods median (#7 of 1951)
No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
64GF Score
Get the complete analysis for WBO:BIO
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BIO has been successfully added to your 